C. Brisson, C. Dermatology, and . Cacoub, Saint Etienne, Internal Medicine Internal Medicine Internal Medicine Internal Medicine

F. Morschhauser, L. Hematology, and . Oksenhendler, Immuno-Hematology, Paris; Yann Ollivier, Internal Medicine, Caen; Fabien Pelletier, Dermatology, Besançon; Dominique Perrotin, Intensive Care Unit, Tours, Internal Medicine

S. Kim, J. Brooks, and J. Sheikh, Angioedema deaths in the United States, 1979???2010, Annals of Allergy, Asthma & Immunology, vol.113, issue.6, pp.630-634, 1979.
DOI : 10.1016/j.anai.2014.09.003

J. Björkqvist, A. Sala-cunill, and T. Renné, Hereditary angioedema: a bradykinin-mediated swelling disorder, Thrombosis and Haemostasis, vol.109, issue.3, pp.368-74, 2013.
DOI : 10.1160/TH12-08-0549

K. Bork, S. Barnstedt, and P. Koch, Hereditary angioedema with normal C1-inhibitor activity in women, The Lancet, vol.356, issue.9225, pp.213-220, 2000.
DOI : 10.1016/S0140-6736(00)02483-1

B. Zuraw, J. Bernstein, and D. Lang, A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor???associated angioedema, Journal of Allergy and Clinical Immunology, vol.131, issue.6, pp.1491-1494, 2013.
DOI : 10.1016/j.jaci.2013.03.034

H. Longhurst and M. Cicardi, Hereditary angio-oedema, The Lancet, vol.379, issue.9814, pp.474-81, 2012.
DOI : 10.1016/S0140-6736(11)60935-5

R. Castelli, D. Deliliers, and L. Zingale, Lymphoproliferative disease and acquired C1 inhibitor deficiency, Haematologica, vol.92, issue.5, pp.716-724, 2007.
DOI : 10.3324/haematol.10769

M. Cicardi, L. Zingale, and E. Pappalardo, Autoantibodies and Lymphoproliferative Diseases in Acquired C1-Inhibitor Deficiencies, Medicine, vol.82, issue.4, pp.274-81, 2003.
DOI : 10.1097/01.md.0000085055.63483.09

V. Frémeaux-bacchi, M. Guinnepain, and P. Cacoub, Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2, The American Journal of Medicine, vol.113, issue.3, pp.194-203, 2002.
DOI : 10.1016/S0002-9343(02)01124-5

M. Cicardi and A. Zanichelli, Acquired angioedema, Allergy, Asthma & Clinical Immunology, vol.6, issue.1, p.14, 2010.
DOI : 10.1186/1710-1492-6-14

L. Bouillet-claveyrolas, D. Ponard, and C. Drouet, Clinical and biological distinctions between type I and type II acquired angioedema, The American Journal of Medicine, vol.115, issue.5, pp.420-421, 2003.
DOI : 10.1016/S0002-9343(03)00396-6

A. Agostoni, E. Aygören-pürsün, and K. Binkley, Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond, Journal of Allergy and Clinical Immunology, vol.114, issue.3, pp.51-131, 2004.
DOI : 10.1016/j.jaci.2004.06.047

A. Zanichelli, M. Bova, and A. Coerezza, Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study, Allergy, vol.164, issue.8, pp.1074-1081, 2012.
DOI : 10.1111/j.1398-9995.2012.02853.x

J. Melamed, C. Alper, and M. Cicardi, The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiency, J Allergy Clin Immunol, vol.77, pp.322-328, 1986.

M. Cugno, M. Cicardi, and A. Agostoni, Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid, Journal of Allergy and Clinical Immunology, vol.93, issue.5, pp.870-876, 1994.
DOI : 10.1016/0091-6749(94)90380-8

A. Branellec, L. Bouillet, and N. Javaud, Acquired C1-Inhibitor Deficiency: 7 Patients Treated with Rituximab, Journal of Clinical Immunology, vol.377, issue.5, pp.936-977, 2012.
DOI : 10.1007/s10875-012-9691-2

P. Ziakas, S. Giannouli, and E. Psimenou, Acquired angioedema: a new target for rituximab?, Haematologica, vol.89, p.13, 2004.

M. Levi, C. Hack, and M. Van-oers, Rituximab-induced Elimination of Acquired Angioedema Due to C1-Inhibitor Deficiency, The American Journal of Medicine, vol.119, issue.8, pp.3-5, 2006.
DOI : 10.1016/j.amjmed.2005.09.018

D. Lam, N. Levy, and J. Nickerson, Acquired Angioedema and Marginal Zone Lymphoma, Journal of Clinical Oncology, vol.30, issue.16, pp.151-154, 2012.
DOI : 10.1200/JCO.2011.38.9957

A. Hassan, S. Amarger, and A. Tridon, Acquired Angioedema Responding to Rituximab, Acta Dermato Venereologica, vol.91, issue.6, pp.733-737, 2011.
DOI : 10.2340/00015555-1157

R. Kaur, A. Williams, and C. Swift, Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema, J Asthma Allergy, vol.7, pp.165-172, 2014.

D. Dreyfus, C. Na, and C. Randolph, Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers, Isr Med Assoc J, vol.16, pp.315-321, 2014.

A. Bygum and H. Vestergaard, Acquired Angioedema - Occurrence, Clinical Features and Associated Disorders in a Danish Nationwide Patient Cohort, International Archives of Allergy and Immunology, vol.162, issue.2, pp.149-55, 2013.
DOI : 10.1159/000351452

C. Drouet, C. Alibeu, and D. Ponard, A sensitive method to assay blood complement C Inhibitor activity, Clinica Chimica Acta, vol.174, issue.2, pp.121-151, 1988.
DOI : 10.1016/0009-8981(88)90379-8

J. Alsenz, K. Bork, and M. Loos, Autoantibody-Mediated Acquired Deficiency of C1 Inhibitor, New England Journal of Medicine, vol.316, issue.22, pp.1360-1366, 1987.
DOI : 10.1056/NEJM198705283162202

A. Banerji, P. Busse, and S. Christiansen, Current state of hereditary angioedema management: A patient survey, Allergy and Asthma Proceedings, vol.36, issue.3, pp.213-220, 2015.
DOI : 10.2500/aap.2015.36.3824

B. Hory, J. Panouse-perrin, and J. Dupond, D??ficit acquis en inhibiteur de la C1 est??rase et syndrome lymphoprolif??ratif, La Revue de M??decine Interne, vol.6, issue.3, pp.266-71, 1985.
DOI : 10.1016/S0248-8663(85)80116-8

B. Grosbois, J. Goasguen, and R. Leblay, D??ficit acquis en inhibiteur de la C1 est??rase et syndromes lymphoprolif??ratifs malins, La Revue de M??decine Interne, vol.6, issue.4, p.464, 1985.
DOI : 10.1016/S0248-8663(85)80109-0

J. Björkqvist, S. De-maat, and U. Lewandrowski, Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III, Journal of Clinical Investigation, vol.125, issue.8, pp.3132-3178, 2015.
DOI : 10.1172/JCI77139DS1

A. Ghannam, P. Sellier, and F. Defendi, C1 inhibitor function using contact-phase proteases as target: evaluation of an innovative assay, Allergy, vol.8, issue.9, pp.1103-1114, 2015.
DOI : 10.1111/all.12657

D. Vincent, D. Ponard, and S. Fiorella, Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency, Annals of Allergy, Asthma & Immunology, vol.114, issue.1, pp.68-70, 2015.
DOI : 10.1016/j.anai.2014.10.008

S. Jolles, P. Williams, and E. Carne, A UK national audit of hereditary and acquired angioedema, Clinical & Experimental Immunology, vol.43, issue.1, pp.59-67, 2014.
DOI : 10.1111/cei.12159

M. Phanish, A. Owen, and D. Parry, Spontaneous regression of acquired C1 esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema, Journal of Clinical Pathology, vol.55, issue.10, pp.789-90, 2002.
DOI : 10.1136/jcp.55.10.789

S. Gaur, J. Cooley, and L. Aish, Lymphoma-associated paraneoplastic angioedema with normal C1-inhibitor activity: Does danazol work?, American Journal of Hematology, vol.103, issue.3, pp.296-304, 2004.
DOI : 10.1002/ajh.20195

M. Lara-jiménez, L. Ruiz-rivera, and C. Magro-checa, Angioedema adquirido por d??ficit de C1 inhibidor secundario a linfoma B espl??nico de la zona marginal, Revista Cl??nica Espa??ola, vol.214, issue.9, pp.107-116, 2014.
DOI : 10.1016/j.rce.2014.05.014

O. Ates, V. Sunar, and T. Babacan, Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab, J BUON, vol.20, p.349, 2015.

R. Castelli, M. Wu, and M. Arquati, High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency, British Journal of Haematology, vol.26, issue.6, pp.902-910, 2016.
DOI : 10.1111/bjh.13908

E. Matutes, D. Oscier, and C. Montalban, Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria, Leukemia, vol.90, issue.3, pp.487-95, 2008.
DOI : 10.1002/hep.1840360702

J. Gelfand, G. Boss, and C. Conley, Acquired C1 Esterase Inhibitor Deficiency and Angioedema, Medicine, vol.58, issue.4, pp.321-329, 1979.
DOI : 10.1097/00005792-197907000-00004

G. Széplaki, L. Varga, and A. Szépvölgyi, Acquired Angioedema Associated with Primary Antiphospholipid Syndrome in a Patient with Antithrombin III Deficiency, International Archives of Allergy and Immunology, vol.146, issue.2, pp.164-172, 2008.
DOI : 10.1159/000113521

C. Martin-garcia, M. Díez-gómez, and E. Camacho, AAE and IgA myeloma, Allergy, vol.106, issue.10, pp.965-971, 2002.
DOI : 10.1034/j.1398-9995.2002.23832_11.x

M. Cicardi, W. Aberer, and A. Banerji, Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group, Allergy, vol.6, issue.Suppl 3, pp.602-618, 2014.
DOI : 10.1111/all.12380